Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
111
1.910
 Why?
Thyroidectomy
13
2019
61
1.750
 Why?
Parathyroidectomy
8
2018
46
1.240
 Why?
Thyroid Diseases
6
2019
27
1.190
 Why?
Parathyroid Neoplasms
5
2015
26
1.040
 Why?
Thyroid Gland
7
2017
77
0.980
 Why?
Parathyroid Hormone
8
2019
143
0.920
 Why?
Vitamin D Deficiency
5
2019
41
0.910
 Why?
Adenoma
4
2017
114
0.910
 Why?
Vitamin D
4
2015
86
0.780
 Why?
Fluorodeoxyglucose F18
6
2013
181
0.710
 Why?
Positron-Emission Tomography
7
2013
297
0.690
 Why?
Radiopharmaceuticals
7
2015
198
0.680
 Why?
Carcinoma, Papillary
4
2017
49
0.680
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.650
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.630
 Why?
Hyperparathyroidism
2
2015
30
0.570
 Why?
Iodine Radioisotopes
3
2015
33
0.540
 Why?
Megestrol Acetate
2
2007
17
0.500
 Why?
Parathyroid Diseases
2
2016
5
0.500
 Why?
Bone Density Conservation Agents
2
2007
75
0.490
 Why?
Nursing Homes
2
2007
111
0.490
 Why?
Incidental Findings
3
2013
43
0.460
 Why?
Proton Pump Inhibitors
1
2015
94
0.450
 Why?
Diphosphonates
1
2015
92
0.450
 Why?
Academic Medical Centers
2
2012
151
0.430
 Why?
Thyroglobulin
2
2013
7
0.430
 Why?
Parathyroid Glands
5
2018
20
0.410
 Why?
Carcinoma, Medullary
2
2010
12
0.410
 Why?
Aged
19
2017
10242
0.410
 Why?
Middle Aged
25
2017
13133
0.400
 Why?
Hypothyroidism
2
2011
56
0.370
 Why?
Male
31
2019
26874
0.360
 Why?
Retrospective Studies
14
2019
6694
0.360
 Why?
Postoperative Complications
5
2018
1065
0.350
 Why?
Calcitonin
2
2010
30
0.350
 Why?
Carcinoma
2
2012
135
0.330
 Why?
Humans
44
2019
52441
0.330
 Why?
Algorithms
1
2013
673
0.320
 Why?
Thyroid Nodule
3
2017
32
0.310
 Why?
Female
29
2019
28277
0.300
 Why?
Weight Loss
2
2009
257
0.290
 Why?
Appetite Stimulants
1
2007
5
0.270
 Why?
Cachexia
1
2007
28
0.260
 Why?
Teriparatide
1
2007
8
0.260
 Why?
Aged, 80 and over
9
2017
3449
0.260
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.250
 Why?
Calcium
3
2018
396
0.240
 Why?
Hypocalcemia
2
2016
13
0.240
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.240
 Why?
Phenylurea Compounds
2
2015
16
0.230
 Why?
Hormones
1
2005
57
0.230
 Why?
Osteoporosis
1
2007
157
0.230
 Why?
Quinolines
2
2015
44
0.230
 Why?
Transcriptional Activation
1
2005
127
0.230
 Why?
Pituitary Gland
1
2005
87
0.220
 Why?
Receptors, Estrogen
1
2005
133
0.220
 Why?
Interleukin-6
1
2005
271
0.210
 Why?
NF-kappa B
1
2005
326
0.210
 Why?
Biopsy, Fine-Needle
5
2011
104
0.200
 Why?
Protein Kinase Inhibitors
2
2015
231
0.200
 Why?
Illinois
2
2013
11
0.190
 Why?
Treatment Outcome
8
2015
5508
0.190
 Why?
Adult
13
2017
14205
0.180
 Why?
Gene Expression Regulation
1
2005
1004
0.170
 Why?
Aging
1
2005
722
0.160
 Why?
Young Adult
7
2015
4346
0.160
 Why?
Follow-Up Studies
3
2013
2294
0.160
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.150
 Why?
Postoperative Period
3
2015
169
0.150
 Why?
Preoperative Care
2
2018
173
0.140
 Why?
Vitamins
2
2018
59
0.140
 Why?
Patient Discharge
3
2016
320
0.140
 Why?
Intraoperative Complications
1
2019
113
0.140
 Why?
Insulin Resistance
2
2009
281
0.130
 Why?
Prospective Studies
2
2013
2433
0.130
 Why?
United States
5
2015
5215
0.130
 Why?
Antineoplastic Agents
2
2015
1216
0.130
 Why?
Predictive Value of Tests
3
2015
938
0.130
 Why?
Reoperation
1
2018
463
0.120
 Why?
Incidence
2
2011
1096
0.120
 Why?
Adolescent
5
2015
6713
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
27
0.120
 Why?
Creatinine
1
2015
156
0.120
 Why?
Lymph Nodes
1
2017
253
0.110
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
50
0.110
 Why?
Costs and Cost Analysis
2
2014
94
0.110
 Why?
Disease Progression
3
2015
870
0.110
 Why?
Diagnosis, Differential
6
2018
1028
0.110
 Why?
Molecular Targeted Therapy
1
2015
135
0.110
 Why?
Ambulatory Care
1
2016
238
0.110
 Why?
Neoplasm Metastasis
2
2015
235
0.110
 Why?
Hospitals, University
1
2014
73
0.100
 Why?
Child, Preschool
2
2013
4046
0.100
 Why?
Sensitivity and Specificity
2
2013
871
0.100
 Why?
Liver
2
2009
1150
0.100
 Why?
Exercise
2
2009
559
0.100
 Why?
Drug Administration Schedule
1
2013
370
0.100
 Why?
Hospitals, Teaching
1
2013
52
0.100
 Why?
Technetium
1
2012
8
0.100
 Why?
Preoperative Period
1
2012
47
0.100
 Why?
Administration, Oral
1
2013
455
0.100
 Why?
Radionuclide Imaging
1
2012
101
0.090
 Why?
Patient Compliance
1
2013
228
0.090
 Why?
Clinical Competence
2
2018
405
0.090
 Why?
Outpatients
1
2013
128
0.090
 Why?
Hospital Charges
1
2012
46
0.090
 Why?
Tumor Burden
1
2012
132
0.090
 Why?
Struma Ovarii
1
2012
5
0.090
 Why?
Cost Savings
1
2012
60
0.090
 Why?
Prognosis
3
2015
2100
0.090
 Why?
Child
3
2013
7194
0.090
 Why?
Ovariectomy
1
2012
115
0.090
 Why?
Immunohistochemistry
2
2012
977
0.090
 Why?
Obesity
2
2009
1176
0.080
 Why?
Chromogranin A
1
2010
5
0.080
 Why?
Dose-Response Relationship, Drug
1
2013
1365
0.080
 Why?
Radiation Monitoring
1
2010
7
0.080
 Why?
Inpatients
1
2011
203
0.080
 Why?
Radiosurgery
1
2011
130
0.080
 Why?
Checklist
1
2010
39
0.080
 Why?
Fatal Outcome
1
2010
193
0.080
 Why?
Databases, Factual
1
2013
721
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
35
0.080
 Why?
Ultrasonography
4
2015
416
0.080
 Why?
Intra-Abdominal Fat
1
2009
20
0.070
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.070
 Why?
General Surgery
1
2010
106
0.070
 Why?
Occupational Exposure
1
2010
111
0.070
 Why?
Blastomycosis
1
2008
31
0.070
 Why?
Receptors, Thyrotropin
1
2007
6
0.070
 Why?
Ovarian Neoplasms
1
2012
455
0.070
 Why?
Symporters
1
2007
18
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Time Factors
3
2015
2987
0.070
 Why?
Whole Body Imaging
1
2007
22
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Severity of Illness Index
1
2011
1045
0.070
 Why?
Adiposity
1
2009
147
0.070
 Why?
DNA, Neoplasm
1
2007
146
0.070
 Why?
Promoter Regions, Genetic
2
2007
465
0.060
 Why?
Calcifediol
1
2006
8
0.060
 Why?
Practice Management, Medical
1
2006
9
0.060
 Why?
Calcium Carbonate
1
2006
10
0.060
 Why?
Medical Audit
1
2006
20
0.060
 Why?
Drug Utilization Review
1
2006
22
0.060
 Why?
Geriatrics
1
2006
41
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
853
0.060
 Why?
Drug Monitoring
1
2006
81
0.060
 Why?
Cross-Sectional Studies
2
2014
1677
0.060
 Why?
Head
1
2006
70
0.060
 Why?
Body Mass Index
2
2009
701
0.060
 Why?
Otolaryngology
1
2006
62
0.060
 Why?
Neck
1
2006
97
0.060
 Why?
Proportional Hazards Models
1
2007
446
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
10
0.060
 Why?
Freezing
1
2005
15
0.060
 Why?
Arkansas
2
2014
2013
0.060
 Why?
Faculty, Medical
1
2006
92
0.060
 Why?
Fractures, Bone
1
2006
105
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Survival Analysis
1
2007
656
0.060
 Why?
DNA Primers
1
2005
204
0.060
 Why?
Reproducibility of Results
3
2017
1223
0.060
 Why?
Internship and Residency
1
2010
438
0.060
 Why?
HeLa Cells
1
2005
243
0.060
 Why?
Base Sequence
1
2005
632
0.050
 Why?
Nuclear Proteins
1
2005
247
0.050
 Why?
Protein Binding
1
2005
673
0.050
 Why?
Infant
1
2012
3709
0.050
 Why?
ROC Curve
2
2015
249
0.050
 Why?
Patient Selection
2
2018
269
0.050
 Why?
Intraoperative Period
2
2015
46
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
625
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1140
0.040
 Why?
Thalidomide
1
2002
376
0.040
 Why?
Glucagon
2
2009
23
0.040
 Why?
Cohort Studies
2
2015
1576
0.040
 Why?
Monitoring, Intraoperative
1
2019
52
0.040
 Why?
Cholecalciferol
1
2018
18
0.040
 Why?
Hospitals, High-Volume
1
2018
26
0.040
 Why?
Medical History Taking
1
2018
46
0.040
 Why?
Risk Factors
1
2006
3971
0.030
 Why?
Pilot Projects
2
2010
725
0.030
 Why?
Methylene Blue
1
2017
7
0.030
 Why?
Lymphatic System
1
2017
13
0.030
 Why?
Societies, Medical
1
2018
200
0.030
 Why?
Animals, Genetically Modified
1
2017
53
0.030
 Why?
Coloring Agents
1
2017
68
0.030
 Why?
Mice, Inbred Strains
1
2017
165
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
75
0.030
 Why?
Insulin
2
2009
485
0.030
 Why?
Recurrence
1
2018
680
0.030
 Why?
Lymphatic Metastasis
1
2017
210
0.030
 Why?
Bone Density
1
2018
396
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
17
0.030
 Why?
Retreatment
1
2015
58
0.030
 Why?
Brachial Plexus
1
2015
12
0.030
 Why?
Endocrinology
1
2015
12
0.030
 Why?
Axilla
1
2015
92
0.030
 Why?
Hematoma
1
2015
67
0.030
 Why?
Transplantation, Autologous
1
2015
479
0.030
 Why?
Neoplasm Staging
1
2015
768
0.020
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
29
0.020
 Why?
Mutation
1
2017
1331
0.020
 Why?
Ribs
1
2010
16
0.020
 Why?
Thoracotomy
1
2010
33
0.020
 Why?
Neck Dissection
1
2010
29
0.020
 Why?
Mediastinal Neoplasms
1
2010
19
0.020
 Why?
Hypercalcemia
1
2010
34
0.020
 Why?
Feasibility Studies
1
2011
404
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
69
0.020
 Why?
Hospitalization
1
2014
731
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Prevalence
1
2012
1016
0.020
 Why?
Glucose Tolerance Test
1
2009
61
0.020
 Why?
Adiponectin
1
2009
47
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
234
0.020
 Why?
Absorptiometry, Photon
1
2009
161
0.020
 Why?
Postmenopause
1
2009
104
0.020
 Why?
Bone Neoplasms
1
2010
188
0.020
 Why?
Eye
1
2008
28
0.020
 Why?
Iodine
1
2007
12
0.020
 Why?
Multiple Myeloma
1
2002
3013
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
639
0.020
 Why?
Methylation
1
2007
124
0.020
 Why?
Body Weight
1
2009
524
0.020
 Why?
Overweight
1
2009
230
0.020
 Why?
Current Procedural Terminology
1
2006
10
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Mice
1
2017
5899
0.020
 Why?
Office Visits
1
2006
45
0.020
 Why?
Polymerase Chain Reaction
1
2007
458
0.020
 Why?
Genetic Predisposition to Disease
1
2009
525
0.020
 Why?
Blood Glucose
1
2009
483
0.020
 Why?
Risk Assessment
1
2010
1349
0.010
 Why?
Lung
1
2008
479
0.010
 Why?
Muscle, Skeletal
1
2009
799
0.010
 Why?
Thyroid Function Tests
1
2002
27
0.010
 Why?
Thyrotropin
1
2002
48
0.010
 Why?
Animals
1
2017
13485
0.010
 Why?
Clinical Trials as Topic
1
2002
461
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department